Nurse Anesthetist - CR in Bolivar, MO Accepting Medicare

4 Nurse Anesthetist - CR nurses found. Showing 1 - 4

Peter Mosca, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 1500 N Oakland Ave, Bolivar, MO 65613 Phone: 660-826-5960    Fax: 660-826-4852

Jason Brooks, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1500 N Oakland Ave, Bolivar, MO 65613 Phone: 417-777-6911    Fax: 660-826-4852

Rodney Hoover, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1500 N Oakland Ave, Bolivar, MO 65613 Phone: 660-826-5960    Fax: 660-826-4852

Jacob Schrader, CRNA Nurse Anesthetist, Certified Registered Medicare: Medicare Enrolled Practice Location: 1500 N Oakland Ave, Bolivar, MO 65613 Phone: 417-326-6000

News Archive

Electronics that interface with biological systems

Imagine a chip, strategically placed in the brain, that could prevent epileptic seizures or allow someone who has lost a limb to control an artificial arm just by thinking about it.

Computational approach can help identify chemoresistant potential targets in cancer stem cells

In cancer, one of the most important features is the methylation of deoxycytosine to form 5-methylcytosine (5mC). DNA methylation is a process by which methyl groups (structural units of organic compounds consisting of three hydrogen atoms bonded to a carbon atom) are added to the DNA molecule.

Study highlights link between poor sleep quality and impact of severe LUTS in some men

Sleep quality may have an impact on the severity of lower urinary tract symptoms, or LUTS, in some men, according to new research presented during the 110th Annual Scientific Meeting of the American Urological Association.

Encorium Group raises $1.6 million through private placement

Encorium Group, Inc., a full-service multinational contract research organization (CRO) that provides design, development, and management capabilities for clinical trials and patient registries to many of the world's leading pharmaceutical companies, today announced that it has completed a private placement of 3,937,500 shares of its common stock with a private investor for an aggregate purchase price of $1,575,000, or $.40 per share.

Read more Medical News

› Verified 2 days ago